Vectors Research Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $353K | Sell |
2,747
-45
| -2% | -$5.27K | 0.09% | 121 |
|
|
2026
Q1 | $336K | Buy |
2,792
+80
| +3% | +$9.24K | 0.1% | 117 |
|
|
2025
Q4 | $285K | Sell |
2,712
-33
| -1% | -$3.1K | 0.09% | 110 |
|
|
2025
Q3 | $230K | Hold |
2,745
| – | – | 0.07% | 124 |
|
|
2025
Q2 | $217K | Sell |
2,745
-11,694
| -81% | -$930K | 0.07% | 111 |
|
|
2025
Q1 | $1.3M | Buy |
14,439
+16
| +0.1% | +$1.49K | 0.45% | 62 |
|
|
2024
Q4 | $1.43M | Sell |
14,423
-1,535
| -10% | -$158K | 0.49% | 58 |
|
|
2024
Q3 | $1.81M | Sell |
15,958
-385
| -2% | -$45.7K | 0.55% | 53 |
|
|
2024
Q2 | $2.02M | Sell |
16,343
-499
| -3% | -$64.3K | 0.62% | 46 |
|
|
2024
Q1 | $2.22M | Sell |
16,842
-1,090
| -6% | -$134K | 0.63% | 43 |
|
|
2023
Q4 | $1.96M | Sell |
17,932
-315
| -2% | -$32.7K | 0.55% | 53 |
|
|
2023
Q3 | $1.75M | Buy |
18,247
+286
| +2% | +$30.8K | 0.57% | 51 |
|
|
2023
Q2 | $2.07M | Sell |
17,961
-1,036
| -5% | -$118K | 0.59% | 49 |
|
|
2023
Q1 | $2.02M | Sell |
18,997
-213
| -1% | -$23K | 0.52% | 49 |
|
|
2022
Q4 | $2.13M | Buy |
19,210
+982
| +5% | +$100K | 0.55% | 47 |
|
|
2022
Q3 | $1.57M | Sell |
18,228
-410
| -2% | -$36.6K | 0.44% | 57 |
|
|
2022
Q2 | $1.7M | Sell |
18,638
-415
| -2% | -$36.8K | 0.43% | 56 |
|
|
2022
Q1 | $1.56M | Buy |
19,053
+301
| +2% | +$23.7K | 0.34% | 69 |
|
|
2021
Q4 | $1.44M | Buy |
18,752
+828
| +5% | +$65.9K | 0.3% | 74 |
|
|
2021
Q3 | $1.35M | Buy |
17,924
+968
| +6% | +$73.6K | 0.32% | 69 |
|
|
2021
Q2 | $1.32M | Sell |
16,956
-367
| -2% | -$27.3K | 0.34% | 70 |
|
|
2021
Q1 | $1.27M | Sell |
17,323
-72
| -0.4% | -$5.31K | 0.35% | 66 |
|
|
2020
Q4 | $1.36M | Buy |
17,395
+7,133
| +70% | +$546K | 0.42% | 56 |
|
|
2020
Q3 | $815K | Sell |
10,262
-84
| -0.8% | -$6.58K | 0.3% | 73 |
|
|
2020
Q2 | $763K | Buy |
10,346
+7,333
| +243% | +$552K | 0.3% | 68 |
|
|
2020
Q1 | $221K | Hold |
3,013
| – | – | 0.11% | 101 |
|
|
2019
Q4 | $261K | Sell |
3,013
-9
| -0.3% | -$739 | 0.11% | 101 |
|
|
2019
Q3 | $243K | Sell |
3,022
-26
| -0.9% | -$2.08K | 0.12% | 102 |
|
|
2019
Q2 | $244K | Buy |
3,048
+1
| +0% | +$77 | 0.13% | 93 |
|
|
2019
Q1 | $242K | Buy |
3,047
+2,464
| +423% | +$184K | 0.14% | 95 |
|
|
2018
Q4 | $43K | Sell |
583
-2,121
| -78% | -$150K | 0.02% | 200 |
|
|
2018
Q3 | $156K | Buy |
+2,704
| New | +$172K | 0.1% | 119 |
|
Other funds holding MRK
Vectors Research Management's MRK Position: Q2 2026 in Review
Vectors Research Management reduced its Merck (MRK) stake by 1.6% in Q2 2026, selling an estimated $5.27K and leaving 2,747 shares worth $353K. The position accounts for 0.09% of the portfolio, ranked #121.
Vectors Research Management first reported a position in MRK in Q3 2018 and has held it in 32 quarters since. The position peaked at $2.22M in Q1 2024. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Vectors Research Management held 2,747 shares of Merck worth $353K as of Q2 2026.
- Vectors Research Management sold 45 Merck shares in Q2 2026, an estimated $5.27K.
- Merck made up 0.09% of Vectors Research Management's portfolio in Q2 2026, its #121 holding.
- Vectors Research Management first reported a position in Merck in Q3 2018 and has held it in 32 quarters since.
- Vectors Research Management's Merck position peaked at $2.22M in Q1 2024.
- 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.